Clinical Trials in Baltimore

Showing 17621-17640 of 23,476 trials

Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.

NCT02159040

The primary objective of the study is to compare the overall response rate (inclusive of complete response, partial response and hematologic improvement) per IWG 2006 criteria in patients with higher risk MDS treated with azacitidine with or without deferasirox achieved over the course of one year. Hematologic improvement must be maintained for at least 8 weeks.

High Risk MDS

Novartis Pharmaceuticals1 participantsStarted Sep 2014

Little Rock, Arkansas, United States • Duarte, California, United States • Baltimore, Maryland, United States +3 more locations

COMPLETEDPhase 2< 1 mile

ABT-436 for Alcohol Dependence

NCT01613014

The primary efficacy endpoint examines the hypothesis that ABT-436 will decrease the weekly percentage of heavy drinking days during Study Weeks 2 through 12 (Days 8-84) as compared to placebo. A "heavy drinking day" is 4 or more drinks per drinking day for women and 5 or more drinks per drinking day for men.

Alcohol DependenceAlcohol AbuseAlcohol Use Disorders+1 more

National Institute on Alcohol Abuse and Alcoholism (NIAAA)150 participantsStarted Feb 2013

Baltimore, Maryland, United States • Boston, Massachusetts, United States • Quincy, Massachusetts, United States +2 more locations

Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox.

ABT-436 for Alcohol Dependence

Find Trials by Condition in Baltimore

The Angel® Catheter Pivotal Clinical Trial

Sudden Deafness Treatment Trial

Trial Comparing Dual Probe Ultrasonic Lithotripsy to a Single Probe Ultrasonic Lithotripsy

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Immune Response in Subjects With Fabry Disease Who Are Switching From Agalsidase Alfa to Agalsidase Beta

Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles

A Safety and Efficacy Study of Tralokinumab in Adults With Asthma

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer

Clinical Trial of Peripheral Prism Glasses for Hemianopia

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Viral Pathogenesis of Early Cystic Fibrosis Lung Disease